Results 61 to 70 of about 2,174 (198)

World Association for Veterinary Dermatology Consensus Statement for Diagnosis, and Evidence‐Based Clinical Practice Guidelines for Treatment and Prevention of Canine Leishmaniosis

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 723-787, December 2025.
Hyperkeratosis of (a) the footpads and (b) the nasal planum. ABSTRACT Background Canine leishmaniosis (CanL) due to Leishmania infantum remains common, and veterinarians do not always follow scientifically sound approaches for diagnosis, treatment and prevention. Objectives To provide consensus guidelines for diagnosis and evidence‐based guidelines for
Manolis N. Saridomichelakis   +9 more
wiley   +1 more source

Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client‐Owned Dogs: A Multicenter, Double‐Masked, Randomised, Placebo‐Controlled Clinical Trial

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 825-837, December 2025.
Background: Inhibition of the Janus kinase pathway is an established treatment for allergic dermatitis. Objective: To evaluate the efficacy and safety of ilunocitinib for control of pruritus in dogs with allergic dermatitis in a randomised, double‐masked clinical trial.
Sophie Forster   +5 more
wiley   +1 more source

Demodex canis regulates cholinergic system mediated immunosuppressive pathways in canine demodicosis

open access: yes, 2017
SUMMARYDemodex canis infestation in dogs remains one of the main challenges in veterinary dermatology. The exact pathogenesis of canine demodicosis is unknown but an aberration in immune status is considered very significant.
S. K. GARG   +6 more
core   +1 more source

Demodicosis: A Neglected Cutaneous Parasitic Disease in Face Lesions Examination [PDF]

open access: yes, 2019
Background: Demodicosis in humans was caused by two species of Demodex called folliculorum and brevis. The disease is seen in male and female. Although, there is no clinical symptoms in individuals with normal immunity system, but in many cases ...
Maraghi, Sharif
core   +1 more source

Reply to: Superficial Pustular Folliculitis of the Face and Neck—A Non‐Infectious Eruption Responding to Topical Steroids

open access: yes
JEADV Clinical Practice, Volume 5, Issue 2, Page 702-703, June 2026.
Jinfeng Liu   +3 more
wiley   +1 more source

Demodicosis generalizada canina tratada con Fluralaner: reporte de un caso [PDF]

open access: yes, 2018
Canine demodicosis is a dermatopathy caused by normal inhabitants of the skin flora of dogs, such as mites (Demodex spp), being determined by the exponential increase compared to the normal number of mites.
Arroyo-Munive, Yasmir José   +1 more
core   +2 more sources

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial

open access: yesVeterinary Dermatology, Volume 36, Issue 5, Page 647-659, October 2025.
Background – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Sophie Forster   +5 more
wiley   +1 more source

Intralipid emulsion therapy for ivermectin toxicity in a dog

open access: yesVeterinary Medicine and Science, Volume 11, Issue 5, September 2025.
Ivermectin is used to treat external parasites such as demodex by binding to glutamate and GABA receptors, causing parasite paralysis. The intralipid emulsion is widely used in poisoning with lipophilic drugs such as ivermectin, and its ease of use in emergency cases has made it applicable.
Ehsan Khaksar   +3 more
wiley   +1 more source

Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.
Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos   +5 more
wiley   +1 more source

Correlation analysis of hormone-immune interactions in patients with demodicosis

open access: yes, 2016
The paper finds the specifies scientific data on the status and relationship of hormonal and immune systems in demodicosis as well as defines their role in the disease pathogenesis.
Чорненька, Жанетта Анатоліївна
core   +1 more source

Home - About - Disclaimer - Privacy